SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-17-204769
Filing Date
2017-06-15
Accepted
2017-06-15 16:47:41
Documents
9
Effectiveness Date
2017-06-15

Document Format Files

Seq Description Document Type Size
1 S-8 d397468ds8.htm S-8 59908
2 EX-5.1 d397468dex51.htm EX-5.1 4585
3 EX-10.1 d397468dex101.htm EX-10.1 126276
4 EX-10.2 d397468dex102.htm EX-10.2 26426
5 EX-10.3 d397468dex103.htm EX-10.3 24566
6 EX-10.4 d397468dex104.htm EX-10.4 26462
7 EX-10.5 d397468dex105.htm EX-10.5 36758
8 EX-10.6 d397468dex106.htm EX-10.6 35302
9 EX-23.2 d397468dex232.htm EX-23.2 1317
  Complete submission text file 0001193125-17-204769.txt   342629
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-218774 | Film No.: 17913979
SIC: 2834 Pharmaceutical Preparations